The third fourth meeting of the President’s Council of Advisers on Science and Technology (PCAST) took place on March 12 in Washington. While the public sessions were limited to that day, remarks by PCAST co-chair (and presidential science adviser) Dr. John Holdren suggest that there was a private session with Food and Drug Administration Commissioner Hamburg on the issue of regulatory science. After the public session, PCAST members met with the President to present the Council’s latest review of the National Nanotechnology Initiative.
You can review the meeting agenda, and watch the public session webcast. Other meeting information (including some presentation slides) is also online.
Working groups within PCAST continue to work between full Council meetings. However, they have stopped giving updates on their progress beyond general comments from Dr. Holdren at the beginning of the meetings. I wish they would resume making more detailed updates in open session. Continue reading